Axsym Ca 125
Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125). 510(k) K964020, from Abbott Laboratories (Abbott Park, IL). Product code LTK, class 2.
As of Nov 21, 2026, K964020 is an FDA 510(k) held by Abbott Laboratories, substantially equivalent on Nov 4, 1997 after 393 days, with 4 recalls tied to it in FDA's recall database.
- Review time: 393 days
- Recalls: 4
- Cited as a predicate by: 1 device
The AxSYM® CA 125™ assay is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative measurement of CA 125 assay values in human serum. The AxSYM® CA 125™ assay is to be used as an aid in monitoring response to therapy for patients with epithelial ovarian cancer.
- Architect Ca 125 Ii AssayK042731 · Fujirebio Diagnostics,Inc. · Nov 19, 2004
| Apr 23, 2007 | Z-1026-2007Failure of the AxSYM instrument to open (actuate) some reagent packs from certain lots. The defects can result in probe crashes if not detected prior to placement of the reagent kit on the AxYM instrument. | Terminated |
| Nov 25, 2003 | Z-0320-04, Z-0318-04, Z-0321-04The CA 125 assay product inserts list the incorrect storage instructions for the CA 125 Calibrators and Controls, and the product information letter (PI-P) shipped with the products to correct the storage conditions,… | Terminated |
- Access OV MonitorK240479 · Beckman Coulter, Inc. · May 10, 2024
- Immulite/Immulite 1000 Om-Ma, Immulite 2000 Om-MaK213510 · Siemens Healthcare Diagnostics Products, Ltd. · Sep 8, 2023
- VITROS Immuodiagnostic Products CA 125 II Reagent PackK221355 · Ortho Clinical Diagnostics · Dec 12, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 7, 1996
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files